Acceleron Pharma XLRN today announced
the pricing of a public offering of 2,400,000 shares of common stock at
a public offering price of $50.00 per share, before underwriting
discounts. In addition, Acceleron has granted the underwriters a 30-day
option to purchase up to an additional 360,000 shares of common stock at
the public offering price, less underwriting discounts. The offering is
expected to close on or about January 28, 2014, subject to satisfaction
of customary closing conditions.
See full press release
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in